FITZGERALD PMHNP PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER FINAL EXAM QUESTIONS AND
CORRECT SOLUTIONS JUST RELEASED THIS YEAR………...
Core Domains:
- Neurobiology and Psychopharmacology
- Psychiatric Assessment and Diagnostic Reasoning
- Psychotherapy and Therapeutic Interventions
- Management of Psychiatric Disorders Across the Lifespan
- Substance Use Disorders and Addictions
- Legal, Ethical, and Professional Standards in PMHNP Practice
- Health Promotion and Disease Prevention in Mental Health
- Cultural Competence and Health Disparities
- Consultation, Collaboration, and Leadership
- Advanced Practice Roles and Scope of Practice
Introduction
This comprehensive examination is designed to assess the advanced knowledge and clinical expertise required for
the Psychiatric Mental Health Nurse Practitioner (PMHNP) role. It evaluates the candidate's ability to synthesize
complex neurobiological concepts, apply psychopharmacological principles, and utilize evidence-based
psychotherapeutic interventions in clinical practice. The exam emphasizes real-world clinical scenarios to assess
diagnostic reasoning, treatment planning, and ethical decision-making. Through a rigorous multiple-choice and
scenario-based format, candidates will demonstrate their capacity to provide holistic, patient-centered mental
health care across the lifespan, manage complex psychiatric conditions, and lead interprofessional teams to
improve mental health outcomes.
,SECTION ONE: QUESTIONS 1 – 100
1. A 32-year-old patient presents with symptoms of major depressive disorder. The PMHNP is considering
initiating pharmacotherapy. Which neurotransmitter systems are primarily implicated in the pathophysiology
of depression?
A. Dopamine and acetylcholine
B. Serotonin, norepinephrine, and dopamine
C. GABA and glutamate
D. Histamine and substance P
🟢 B. Serotonin, norepinephrine, and dopamine
🔴 RATIONALE: The monoamine hypothesis of depression suggests that deficiencies in serotonin,
norepinephrine, and dopamine are central to the pathophysiology of depressive disorders. These
neurotransmitters regulate mood, motivation, and arousal. While other systems are involved, these three are the
primary targets of most antidepressant medications.
2. A patient with schizophrenia has been stable on risperidone for 2 years but now presents with new-onset,
involuntary, repetitive movements of the tongue and face. What is the most likely diagnosis?
A. Acute dystonia
B. Akathisia
C. Tardive dyskinesia
D. Parkinsonism
🟢 C. Tardive dyskinesia
🔴 RATIONALE: Tardive dyskinesia is a potentially irreversible movement disorder characterized by involuntary,
repetitive, and purposeless movements, especially of the tongue, face, and jaw (e.g., lip smacking, tongue
protrusion). It is a late-onset side effect of antipsychotic medications, particularly first-generation agents. This is
distinct from acute dystonia, akathisia, and parkinsonism, which are early-onset extrapyramidal symptoms.
,3. A 45-year-old patient with a history of alcohol use disorder is prescribed disulfiram. The PMHNP should
educate the patient about which potential reaction if alcohol is consumed?
A. Hypertensive crisis
B. Serotonin syndrome
C. Disulfiram-like reaction
D. Hepatotoxicity
🟢 C. Disulfiram-like reaction
🔴 RATIONALE: Disulfiram blocks the metabolism of alcohol by inhibiting aldehyde dehydrogenase, leading to
an accumulation of acetaldehyde. This causes a severe and unpleasant reaction (flushing, nausea, vomiting,
palpitations, headache) when alcohol is consumed, serving as a deterrent. The patient must be educated to
avoid alcohol completely while taking this medication.
4. A PMHNP is evaluating a patient who reports sudden onset of intense fear, palpitations, and shortness of
breath that peaks within 10 minutes. The patient fears they are "going crazy" and has been having these
episodes for the past month. Which diagnosis is most consistent with these symptoms?
A. Generalized anxiety disorder
B. Social anxiety disorder
C. Panic disorder
D. Post-traumatic stress disorder
🟢 C. Panic disorder
🔴 RATIONALE: Panic disorder is characterized by recurrent, unexpected panic attacks, which involve abrupt
surges of intense fear or discomfort, peaking within minutes, and accompanied by palpitations, shortness of
breath, and fear of losing control or "going crazy." The symptoms described are classic for a panic attack. The
fear of having additional attacks or their consequences differentiates it from other anxiety disorders.
, 5. A patient with bipolar disorder is prescribed lithium. Which laboratory value should the PMHNP monitor
most closely to ensure safe and effective dosing?
A. Serum creatinine
B. Serum potassium
C. Serum lithium
D. Serum sodium
🟢 C. Serum lithium
🔴 RATIONALE: Lithium has a narrow therapeutic range (0.6-1.2 mEq/L). Monitoring serum lithium levels is
essential to maintain therapeutic efficacy and prevent toxicity. Toxicity can occur at levels >1.5 mEq/L and can
be life-threatening, causing severe neurological and gastrointestinal symptoms. While serum sodium, creatinine,
and potassium are also monitored, lithium levels are the most critical for dosing safety.
6. A 16-year-old patient is diagnosed with attention-deficit/hyperactivity disorder (ADHD). The PMHNP is
considering pharmacotherapy. Which medication is considered a first-line treatment for ADHD?
A. Bupropion
B. Atomoxetine
C. Methylphenidate
D. Clonidine
🟢 C. Methylphenidate
🔴 RATIONALE: Psychostimulants, such as methylphenidate and amphetamines, are considered first-line
pharmacotherapy for ADHD due to their high efficacy and rapid onset of action. Atomoxetine and bupropion
are non-stimulant options that are considered second-line. Clonidine is an alpha-2 agonist sometimes used as
an adjunctive treatment.
7. A patient with major depressive disorder is prescribed a selective serotonin reuptake inhibitor (SSRI). The
PMHNP should instruct the patient that the full therapeutic effect may not be seen for how long?
CORRECT SOLUTIONS JUST RELEASED THIS YEAR………...
Core Domains:
- Neurobiology and Psychopharmacology
- Psychiatric Assessment and Diagnostic Reasoning
- Psychotherapy and Therapeutic Interventions
- Management of Psychiatric Disorders Across the Lifespan
- Substance Use Disorders and Addictions
- Legal, Ethical, and Professional Standards in PMHNP Practice
- Health Promotion and Disease Prevention in Mental Health
- Cultural Competence and Health Disparities
- Consultation, Collaboration, and Leadership
- Advanced Practice Roles and Scope of Practice
Introduction
This comprehensive examination is designed to assess the advanced knowledge and clinical expertise required for
the Psychiatric Mental Health Nurse Practitioner (PMHNP) role. It evaluates the candidate's ability to synthesize
complex neurobiological concepts, apply psychopharmacological principles, and utilize evidence-based
psychotherapeutic interventions in clinical practice. The exam emphasizes real-world clinical scenarios to assess
diagnostic reasoning, treatment planning, and ethical decision-making. Through a rigorous multiple-choice and
scenario-based format, candidates will demonstrate their capacity to provide holistic, patient-centered mental
health care across the lifespan, manage complex psychiatric conditions, and lead interprofessional teams to
improve mental health outcomes.
,SECTION ONE: QUESTIONS 1 – 100
1. A 32-year-old patient presents with symptoms of major depressive disorder. The PMHNP is considering
initiating pharmacotherapy. Which neurotransmitter systems are primarily implicated in the pathophysiology
of depression?
A. Dopamine and acetylcholine
B. Serotonin, norepinephrine, and dopamine
C. GABA and glutamate
D. Histamine and substance P
🟢 B. Serotonin, norepinephrine, and dopamine
🔴 RATIONALE: The monoamine hypothesis of depression suggests that deficiencies in serotonin,
norepinephrine, and dopamine are central to the pathophysiology of depressive disorders. These
neurotransmitters regulate mood, motivation, and arousal. While other systems are involved, these three are the
primary targets of most antidepressant medications.
2. A patient with schizophrenia has been stable on risperidone for 2 years but now presents with new-onset,
involuntary, repetitive movements of the tongue and face. What is the most likely diagnosis?
A. Acute dystonia
B. Akathisia
C. Tardive dyskinesia
D. Parkinsonism
🟢 C. Tardive dyskinesia
🔴 RATIONALE: Tardive dyskinesia is a potentially irreversible movement disorder characterized by involuntary,
repetitive, and purposeless movements, especially of the tongue, face, and jaw (e.g., lip smacking, tongue
protrusion). It is a late-onset side effect of antipsychotic medications, particularly first-generation agents. This is
distinct from acute dystonia, akathisia, and parkinsonism, which are early-onset extrapyramidal symptoms.
,3. A 45-year-old patient with a history of alcohol use disorder is prescribed disulfiram. The PMHNP should
educate the patient about which potential reaction if alcohol is consumed?
A. Hypertensive crisis
B. Serotonin syndrome
C. Disulfiram-like reaction
D. Hepatotoxicity
🟢 C. Disulfiram-like reaction
🔴 RATIONALE: Disulfiram blocks the metabolism of alcohol by inhibiting aldehyde dehydrogenase, leading to
an accumulation of acetaldehyde. This causes a severe and unpleasant reaction (flushing, nausea, vomiting,
palpitations, headache) when alcohol is consumed, serving as a deterrent. The patient must be educated to
avoid alcohol completely while taking this medication.
4. A PMHNP is evaluating a patient who reports sudden onset of intense fear, palpitations, and shortness of
breath that peaks within 10 minutes. The patient fears they are "going crazy" and has been having these
episodes for the past month. Which diagnosis is most consistent with these symptoms?
A. Generalized anxiety disorder
B. Social anxiety disorder
C. Panic disorder
D. Post-traumatic stress disorder
🟢 C. Panic disorder
🔴 RATIONALE: Panic disorder is characterized by recurrent, unexpected panic attacks, which involve abrupt
surges of intense fear or discomfort, peaking within minutes, and accompanied by palpitations, shortness of
breath, and fear of losing control or "going crazy." The symptoms described are classic for a panic attack. The
fear of having additional attacks or their consequences differentiates it from other anxiety disorders.
, 5. A patient with bipolar disorder is prescribed lithium. Which laboratory value should the PMHNP monitor
most closely to ensure safe and effective dosing?
A. Serum creatinine
B. Serum potassium
C. Serum lithium
D. Serum sodium
🟢 C. Serum lithium
🔴 RATIONALE: Lithium has a narrow therapeutic range (0.6-1.2 mEq/L). Monitoring serum lithium levels is
essential to maintain therapeutic efficacy and prevent toxicity. Toxicity can occur at levels >1.5 mEq/L and can
be life-threatening, causing severe neurological and gastrointestinal symptoms. While serum sodium, creatinine,
and potassium are also monitored, lithium levels are the most critical for dosing safety.
6. A 16-year-old patient is diagnosed with attention-deficit/hyperactivity disorder (ADHD). The PMHNP is
considering pharmacotherapy. Which medication is considered a first-line treatment for ADHD?
A. Bupropion
B. Atomoxetine
C. Methylphenidate
D. Clonidine
🟢 C. Methylphenidate
🔴 RATIONALE: Psychostimulants, such as methylphenidate and amphetamines, are considered first-line
pharmacotherapy for ADHD due to their high efficacy and rapid onset of action. Atomoxetine and bupropion
are non-stimulant options that are considered second-line. Clonidine is an alpha-2 agonist sometimes used as
an adjunctive treatment.
7. A patient with major depressive disorder is prescribed a selective serotonin reuptake inhibitor (SSRI). The
PMHNP should instruct the patient that the full therapeutic effect may not be seen for how long?
